The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas

Overview of attention for article published in Clinical Cancer Research, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 1 X user

patent: 25 patents

Citations

dimensions_citation: 46 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 7,428 followers.

The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII- http://t.co/vcuq31IAEG http://t.co/v1oC4EkLeE

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.